Skip to main content

Site notifications

AusPAR: Rivaroxaban

Australian Public Assessment Report
Device/Product Name
Xarelto
Active ingredients
Rivaroxaban
AusPAR Date
Published
Submission Number
PM-2011-03916-3-3
Submission Type
Extension of indications, New strength
Decision
Withdrawn

Help us improve the Therapeutic Goods Administration site